Patent · US Active

Process for the enantioselective reduction and oxidation, respectively, of steroids

US8227208B2 · kind B2 · utility

1Cited by
6References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 11, 2007
Grant dateJul 24, 2012
Priority date
Expiry dateJun 13, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P41/002
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A process for the enantioselective reduction of compounds having a steroid structure (ABCD) including one or several heteroatoms, one or several double bonds and/or aromatic components in the ring structure and having at least one oxo group at positions 3, 7, 11, 12 or 17 in the steroid ring system or in the a-position of any carbon moiety of the steroid structure:comprising providing the oxosteroid compound in the reaction at a concentration of ≧50 g/L, a reduced cofactor NADH or NADPH, a hydroxysteroid dehydrogenase and a secondary alcohol or cycloalknaol to effect the enantioselective reduction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.